Dehydroepiandrosterone and analogs inhibit DNA binding of AP-1 and airway smooth muscle proliferation

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 2, 1998, Pages 876-883

  Dashtaki, Rustom ^a   Whorton, A Richard ^b   Murphy, Thomas M ^b   Chitano, Pasquale ^b   Reed, William ^c   Kennedy, Thomas P ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA BROMOEPIANDROSTERONE; ANDROGEN; CHOLESTEROL; DEOXYRIBONUCLEOSIDE; DEXAMETHASONE; DIMETHYL SULFOXIDE; DNA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MEVALONIC ACID; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR AA; PRASTERONE; PROTEIN P21; RIBONUCLEOSIDE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; FETAL CALF SERUM; GENE EXPRESSION; GROWTH INHIBITION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; TRACHEA MUSCLE;

EID: 0031808630     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ and Barnes PJ (1995a) Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 268 (Cell Physiol 37):C331-C338.
2. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH and Barnes PJ (1995b) Differences in binding of glucocorticoid receptor to DNA in steroid resistant asthma. J Immunol 154:3500-3505.
3. American Thoracic Society: Medical section of the National Tuberculosis Association (1962) Chronic bronchitis, asthma, and pulmonary emphysema. A statement by the committee on diagnostic standards for non-tuberculous disease. Am Rev Respir Dis 85:762-768.
4. Angel P and Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157.
5. Becker S, Koren HS and Henke DC (1993) Interleukm-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol 8:20-27.
6. Bernstein LR, Ferris DK, Colburn NH and Sobel ME (1994) A family of mitogen-activated protein kinase-related proteins interacts in vivo with activator proiein-1 transcription factor. J Biol Chem 269:9401-9404.
7. Bramley AM, Thomson RJ, Roberts CR and Schellenberg RR (1994) Excessive bronchoconstriction in asthma is due to decreased airway elastance. Eur Respir J 7:337-341.
8. Brown JP, Breville WH and Finucane KE (1984) Asthma and irreversible airflow obstruction. Thorax 39:131-136.
9. 2+-independent arachidonic acid release by vascular endothelium requires protein synthesis de novo. Biochem J 300:440-449.
10. Didonato JA, Saatcioglu F and Karin M (1996) Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 154:S11-S15.
11. Dworkin CR, German SD, Pashko LL, Cristofalo WJ and Schwartz AG (1986) Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo-and deoxyribonucleosides. Life Sci 38:1451-1457.
12. Ebeling P and Kovisto VA (1994) Physiologic importance of dehydroepiandrosterone. Lancet 343:1479-1481.
13. Ebina M, Takahasi T, Chiba T and Motomiya M (1993) Cellular hypertrophy and hyperplasia of airway smooth muscle underlying bronchial asthma. Am Ret Respir Dis 148:720-726.
14. Eich DM, Nestler JE, Johnson DE, Dworkin GH, Ko D, Wechsler AS and Hess ML (1993) Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 87:261-269.
15. Fryer A, Huang Y-C, Rao G, Jacoby D, Mancilla E, Whorton R, Piantadosi CA, Kennedy T and Hoidal J (1997) Selective O-desulfation produces non anticoagulant heparin that retains pharmacological activity in the lung. J Pharmacol Exp Ther 282:208-219.
16. Garcea R, Daino L, Frassetto S, Cozzolino P, Ruggiu ME, Vannini MG, Pascale R, Lenzerini L, Simile MM, Puddu M and Feo F (1988) Reversal by ribo-and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme-altered foci in the liver of rats subjected to the initiation-selection process of experimental carcinogenesis. Carcinogenesis 9:931-938.
17. Gordon GB, Shantz LM and Talalay P (1987) Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. Adv Enzyme Regul 26:355-382.
18. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P and Cato ACB (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 17:4087-4095.
19. Hirst SJ, Barnes PJ and Twort CHC (1992) Quantifying proliferation of cultured human and rabbit airway smooth muscle in response to serum and platelet derived growth factor. Am J Respir Cell Mol Biol 7:574-581.
20. James AL, Hogg JC, Dunn LA and Pare PD (1988) The use of internal perimeter to compare airway size and to calculate smooth muscle shortening. Am Rev Respir Dis 138:136-139.
21. James AL, Pare PD and Hogg JC (1989) The mechanics of airway narrowing in asthma. Am Rev Respir Dis 139:242-246.
22. Jonat C, Rahmsdorf HJ, Park KK, Cato ACB, Gebel S, Ponta H and Herrlich P(1990) Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
23. Jones JT and Andrews SG (1978) Glucose-6-phosphate dehydrogenase activity in somatic and germinal cells of the mouse testis. J Reproduc Fertility 54:357-362.
24. Juniper EF, Kline PA, Vanieleghem MA, Ramsdale EH, O'Byrne PM and Hargreave FE (1990) Effect of long-term treatment with an inhaled corticosteroid (budesonide) of airway hyperresponsiveness and clinical asthma in non-steroid dependent asthmatics. Am Rev Respir Dis 142:832-836.
25. Kyrikis JM, Bangrjee P, Nilolakaki E, Dai T, Rubie EA, Ahman MF, Avruch J and Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond) 369:156-160.
26. Lambert RK, Wiggs BR, Kuwano K, Hogg JC and Pare PD (1993) Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 74:2771-2781.
27. Lee W, Mitchell P and Tijan R (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
28. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL and Daynes RA (1992) The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Molec Biol 42:293-304.
29. O'Malley BW (1990) The steroid receptor superfamily: More excitement predicted for the future. Mol Endocrinol 4:363-369.
30. Paliogianni F, Raptis A, Ahuja SS, Najjar SM and Boumpas DT (1993) Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest 91:1481-1489.
31. Panettieri RA Jr (1997) Regulation of growth of airway smooth muscle by second messenger systems, in Airway Wall Remodelling in Asthma (Stewart AG, ed) pp. 229-256, CRC Press, Boca Raton, FL.
32. Pare PD, Wiggs BR, Hogg JC and Bosken C (1991) The comparative mechanics and morphology of airways in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 143:1189-1193.
33. Pashko LL, Lewbart ML and Schwartz AG (1991) Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16α-fluoro-5-anderosten-17-one and its reversal by deoxyribonucleosides. Carcinogenesis 12:2189-2192.
34. Pearce D and Yamamoto KR (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science Wash DC 259:1161-1165.
35. Regelson W and Kalimi M (1994) Dehydroepiandrosterone (DHEA) - the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann NY Acad Sci 719:564-575.
36. Schule R, Rangarajan P, Kliever S, Ransone LJ, Bolado J, Yang N, Verma IM and Evans RM (1990) Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 62:1217-1226.
37. ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro. Cancer Res 51:6563-656.
38. Schulz S, Klann RC, Schonfeld S and Nyce JW (1992) Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: Role of isoprenoid biosynthesis. Cancer Res 52:1372-1376.
39. Schwartz AG, Lewbart ML and Pashko LL (1988a) Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats. Cancer Res 48:4817-4822.
40. Schwartz AG and Pashko LL (1995) Mechanism of cancer preventive action of DHEA. Role of glucose-6-phosphate dehydrogenase. Ann NY Acad Sci 774:180-186.
41. Schwartz AG, Whitcomb JM, Nyce JW, Lewbart ML and Pashko LL (1988b) Dehydroepiandrosterone and structural analogs: A new class of cancer chemopreventive agents. Adv Cancer Res 51:391-423.
42. Yang YU, Schwartz A and Henderson EE (1993) Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res Hum Retroviruses 9:747-754.
43. Yang-Yen HF, Chambard JC, Sun YL, Smeal TJ, Schmidt TJ, Drouin J and Karin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.